Headache and Facial Pain Syndromes
Headache and Facial Pain Syndromes
Please click on the link below to access the most up-to-date version of this guideline. The content on this page is currently being updated to align with the latest publication. Always check the version number at the bottom of the screen to confirm which version you are using.
Idiopathic intracranial hypertension (pseudotumour celebri)
MIGRAINE
G43.0-3/G43.8-9
DESCRIPTION
- A migraine is an episodic headache, usually located unilaterally and throbbing/ pulsating in nature, which may occur with or without an aura.
- Migraines are usually accompanied by nausea and/or vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to noise).
- There are several variants of migraine.
GENERAL MEASURES
- Reassure patient that this is a benign condition.
- Attempt to identify any precipitating factors or food triggers from the patient's history.
MEDICINE TREATMENT
Acute treatment
Initiate therapy during the migraine attack or at the onset of the headache.
Analgesia:
- Paracetamol, oral, 500 mg–1 g, 4–6 hourly as required (to a maximum of 4 g in 24 hours).
- Maximum dose: 15 mg/kg/dose.
OR
- NSAID, e.g.:
- Ibuprofen, oral, 400 mg immediately then 8 hourly with meals, if needed.
For nausea:
- Metoclopramide, oral/IM, 10 mg 8 hourly, as required.
Prophylaxis (Z29.2)
Regular, daily, prophylactic therapy is advised if:
- attacks are frequent, i.e. more than 2–3 per month, or
- severe, causing a significant amount of disability, or
- attacks are long lasting, or
- patient poorly tolerates therapy for acute attacks.
LoE:IIIaxlvi
- Amitriptyline, oral, 10–25 mg at bedtime.
- Up-titrate dose to adequate clinical response.
- Doses greater than 75 mg are seldom required.
LoE:IIbxlvii
OR
Poor response or contraindication to amitriptyline:
- β-blocker, e.g.:
- Propranolol, oral, 40 mg 12 hourly.
- Titrate dose to adequate response.
- Maximum dose 120-240 mg daily.
- Propranolol, oral, 40 mg 12 hourly.
LoE:IIIbxlviii
REFERRAL
- Inadequate response to treatment.
CLUSTER HEADACHE
G44.0
DESCRIPTION
- Repetitive episodes of excruciating headache typically of short duration (up to 2 hours) in clusters for weeks to months at a time.
- Typically, the headache is of sudden onset, unilateral during the specific cluster, and quickly reaches a climax.
- Associated redness of the eye with lacrimation and rhinorrhoea occurs.
MEDICINE TREATMENT
- Oxygen inhalation may abort some episodes.
LoE:IIIbxlix
Analgesics are ineffective.
To induce rapid remission in patients with episodic cluster headache:
- Corticosteroids (intermediate-acting) e.g.:
- Prednisone, oral, 40 mg daily for 5–10 days.
- Tapering is not necessary when the above duration is used.
LoE:IVbl
Prophylaxis
- Verapamil, oral, 40-80 mg 12 hourly.
REFERRAL
- Inadequate response to treatment.
TRIGEMINAL NEURALGIA
G50.0
See: Management of neuropathic pain.
TENSION HEADACHE
G44.2
DESCRIPTION
- Tension headaches are described as a tight band around the head and are generally worse in the afternoon.
- Usually occurs over the back of the head, but may extend over the entire head.
GENERAL MEASURES
- Consider use of relaxation techniques.
- Exclude medication overuse headache (see: Medication overuse headache).
MEDICINE TREATMENT
- Amitriptyline, oral, 10–75 mg at night.
REFERRAL
- Atypical pain and/or focal neurological signs and symptoms suggestive of alternate diagnosis.
- Poor response to therapy.
MEDICATION OVERUSE HEADACHE
G44.4
DESCRIPTION
- Medication overuse headache generally occurs for ≥ 15 days per month for more than 3 months, and develops as a consequence of regular overuse of analgesics for acute pain-relief.
- The headache develops or markedly worsens during medication overuse, and usually, but not invariably, resolves after the overuse is stopped.
LoE:IVbli
GENERAL MEASURES
- Stop all analgesics.
- Counsel patient regarding the link between overuse of analgesics and the development of and/or worsening of the headache symptom.
- The headache usually resolves after the overuse is stopped, but may transiently worsen.
MEDICINE TREATMENT
- Amitriptyline, oral, 10 mg at night.
- Increase to a maximum of 75 mg at night.
LoE:IIIblii
-
May be used during withdrawal of acute or symptomatic headache treatment.
- Increase to a maximum of 75 mg at night.
IDIOPATHIC INTRACRANIAL HYPERTENSION (PSEUDOTUMOUR CEREBRI)
G93.2
DESCRIPTION
- Patients present with symptoms (chronic headache, visual disturbance or loss due to papilloedema and tinnitus) and signs (papilloedema) of raised intracranial pressure without structural intracranial abnormality and with normal CSF composition.
Diagnosis
All patients should have neuro-imaging (CT scan).
- If this is normal, i.e. the absence of structural lesions or hydrocephalus, perform a lumbar puncture and measure intracranial pressure.
- Diagnosis is confirmed by the presence of raised CSF pressure > 20 cm H20.
GENERAL MEASURES
- Stop medicines associated with benign intracranial hypertension (e.g. doxycycline, corticosteroids, combined oral contraceptives).
- Regular monitoring of visual fields is crucial.
- Weight loss.
- Repeated lumbar punctures with measurement of opening pressure (do lumbar puncture with patient in left lateral position).
- Consider surgery if there is progression of visual defects, despite medical therapy, visual loss at onset or severe papilloedema.
MEDICINE TREATMENT
Discuss all cases with a specialist.
For visual involvement, persistent headaches, or severe papilloedema:
- Acetazolamide, oral, 250 mg 12 hourly
- Increase, as required, by 250 mg daily every week to the maximum tolerated dose (not exceeding 4 g daily).
LoE:IIIbliii
OR
- Furosemide, oral, 40 mg daily.
REFERRAL
- For neuro-imaging, if not available locally.
- Visual symptoms or deterioration of visual fields for ophthalmology evaluation.
- Patients not responding to therapy or in need of surgical management.
Standard Treatment Guidelines and Essential Medicines List for South Africa, Adult Hospital Level, 2020-4_Version 2.0_6 June 2025
Chapter 14 Neurological Disorders_14.7 Headache and Facial Pain Syndromes
Drugs mentioned
ICD-10 codes
- G43.0Migraine without aura [common migraine]
- G43.1Migraine with aura [classical migraine]
- G43.2Status migrainosus
- G43.3Complicated migraine
- G43.8Other migraine
- G43.9Migraine, unspecified
- G44.0Cluster headache syndrome
- G44.2Tension-type headache
- G44.4Drug-induced headache, not elsewhere classified
- G50.0Trigeminal neuralgia
- G93.2Benign intracranial hypertension
- Z29.2Other prophylactic chemotherapy